{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"AC Immune SA"},"Symbol":{"label":"Symbol","value":"ACIU"},"Address":{"label":"Address","value":"EPFL INNOVATION PARK BUILDING B, LAUSANNE, 1015, Switzerland"},"Phone":{"label":"Phone","value":"+41 216939121"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding."},"CompanyUrl":{"label":"Company Url","value":"https://www.acimmune.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Andrea Pfeifer","title":"Chief Executive Officer &amp; Director"},{"name":"Johannes Rolf Streffer","title":"Chief Medical Officer"},{"name":"Marie Kosco-Vilbois","title":"Chief Scientific Officer"},{"name":"Oliver Sol","title":"VP &amp; Head-Clinical Development"},{"name":"Piergiorgio Donati","title":"Chief Technical Operations Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}